What's next in tech
Genitope, the beleaguered Fremont biopharmaceutical that halted development of its experimental MyVax treatment for non-Hodgkin’s lymphoma last March after the Food and Drug Administration said at least one Read More → 
Avistar Communications was warned again by Nasdaq last month that its shares are at risk of being delisted from its stock market listings. It was warned earlier this Read More → 
Quantum (NYSE:QTM), the San Jose maker of storage products, received word from the New York Stock Exchange that it is "not in compliance" with its minimum $1 listing requirement. It Read More → 
In the world of reverse-splits, it rarely gets as dramatic as this. BroadVision of Redwood City said Friday it completed its 1-for-25 split, meaning that shareholders received one Read More → 
Avistar Communications got a letter from the Nasdaq stock market last week telling the company that it is back in compliance with the rule requiring companies it lists to have Read More → 
Not that this is a shock, but Genitope, the beleaguered biotech that warned in May that it had only enough cash to continue operations through June 2008 and that Read More → 
